Recently, Potti Lan, the marketing director of GEEKVAPE, stated in an interview with VapingPost that the company has been selling its products in over 70 countries around the world, with its main markets being in Europe and the United States. Specifically, France and the United Kingdom are the two primary markets in Europe for GEEKVAPE's products.
Potti Lan said that the European market is very different for GEEKVAPE because it is stable. This is different from Southeast Asia where legislation is constantly changing or the United States where marketing is always seeking new things.
Potti Lan stated that the Aegis series is GEEKVAPE's best-selling product. Since last year, GEEKVAPE has also launched the Wenax and U series, which use pods and have been very popular. In terms of regional differences, he believes that all markets are very fond of the Aegis series.
Additionally, while the disposable e-cigarette brand GEEKBAR is very popular in the United Kingdom, in France the most popular products are traditional tobacco cigarettes.
Caption: Potti Lan, marketing director of GEEKVAPE | Image source: VapingPost
Reference:
Geekvape has announced that their upcoming industrial park will be fifteen times larger than their current location.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
